Home / Belgium / Argenx

Argenx

Short position disclosed on October 20, 2026.

1.10% of the capital sold short

2 disclosing funds

86 disclosures on record

NL0010832176 ISIN code

Evolution of the disclosed total

0%0.5%1%1.5%

Jan 2026Apr 2026Jul 2026Oct 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 2.19% on March 20, 2019. The shaded band matches the twelve months of the first chart.

June 27, 2018 today

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
Marshall Wace LLP		0.59%	new	October 14, 2026
D. E. Shaw & CO., L.P.		0.51%	new	October 20, 2026

In the United States ARGNF (OTC): 61,252 shares sold short on September 30, 2026. FINRA names no fund.

On the other side: the funds that hold Argenx Titelia

Follow by RSS

Get the moves on Argenx by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

86 disclosures on record for this share.
Date	Fund	% of capital	End of publication
March 20, 2019	Citadel Advisors LLC	0.50%	March 25, 2019
March 18, 2019	Millennium Internation Management LP	0.58%	April 30, 2019
March 15, 2019	Marshall Wace LLP	1.11%	March 26, 2019
March 15, 2019	Millennium Internation Management LP	0.61%	March 18, 2019
March 11, 2019	Marshall Wace LLP	1.02%	March 15, 2019
March 6, 2019	Marshall Wace LLP	0.91%	March 11, 2019
March 4, 2019	Marshall Wace LLP	0.82%	March 6, 2019
February 27, 2019	Marshall Wace LLP	0.71%	March 4, 2019
February 19, 2019	Marshall Wace LLP	0.62%	February 27, 2019
February 4, 2019	Marshall Wace LLP	0.52%	February 19, 2019
January 21, 2019	Marshall Wace LLP	0.59%	January 24, 2019
January 15, 2019	Marshall Wace LLP	0.68%	January 21, 2019
January 14, 2019	Marshall Wace LLP	0.76%	January 15, 2019
January 14, 2019	Citadel Advisors LLC	0.50%	January 22, 2019
January 11, 2019	Healthcor Management, L.P.	0.52%	January 15, 2019
January 9, 2019	Marshall Wace LLP	0.89%	January 14, 2019
January 2, 2019	Citadel Advisors LLC	0.51%	January 10, 2019
December 28, 2018	Marshall Wace LLP	0.91%	January 9, 2019
December 21, 2018	Marshall Wace LLP	0.84%	December 28, 2018
December 19, 2018	Marshall Wace LLP	0.70%	December 21, 2018
December 12, 2018	Marshall Wace LLP	0.69%	December 19, 2018
December 10, 2018	Marshall Wace LLP	0.70%	December 12, 2018
December 6, 2018	Marshall Wace LLP	0.67%	December 10, 2018
December 4, 2018	Marshall Wace LLP	0.58%	December 6, 2018
December 3, 2018	Marshall Wace LLP	0.60%	December 4, 2018
November 27, 2018	Marshall Wace LLP	0.87%	December 3, 2018
November 21, 2018	Marshall Wace LLP	0.94%	November 27, 2018
November 20, 2018	Marshall Wace LLP	1.09%	November 21, 2018
November 19, 2018	Marshall Wace LLP	1.11%	November 20, 2018
November 14, 2018	Marshall Wace LLP	1.03%	November 19, 2018
November 12, 2018	Marshall Wace LLP	0.91%	November 14, 2018
November 6, 2018	Marshall Wace LLP	0.80%	November 12, 2018
November 1, 2018	Marshall Wace LLP	0.71%	November 6, 2018
October 25, 2018	Marshall Wace LLP	0.63%	November 1, 2018
October 19, 2018	Marshall Wace LLP	0.50%	October 25, 2018
June 27, 2018	Marshall Wace LLP	0.51%	July 2, 2018

Download 86 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Belgium

Solvay 1.89% of the capital sold short
EVS 1.31% of the capital sold short
Umicore 1.20% of the capital sold short
Melexis 0.95% of the capital sold short
Bekaert 0.84% of the capital sold short
Azelis 0.70% of the capital sold short
D'Ieteren Group 0.69% of the capital sold short
Sequana Medical 0.69% of the capital sold short
Lotus Bakeries 0.59% of the capital sold short
Montea 0.50% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Argenx, source FSMA, data as at October 20, 2026, https://www.quivad.com/action/argenx?page=2